ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,304.72
      0.70%
      US Tech 100
      18,312.00
      0.91%
      Dow Jones
      39,069.59
      0.01%
      Brent Oil
      81.965
      0.81%
      Bitcoin
      68,798.90
      1.29%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. USOTC
      6. Nuo Therapeutics Inc (QB) (AURX)

      7. Nuo Therapeutics Inc (QB) (AURX) News

      AURX

      Nuo Therapeutics (QB) (AURX)

      Nuo Therapeutics Inc (QB)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:USOTC:AURX
      DateTimeSourceHeadlineSymbolCompany
      05/22/202412:40PMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:AURXNuo Therapeutics Inc (QB)
      05/21/20243:13PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:AURXNuo Therapeutics Inc (QB)
      05/21/20243:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:AURXNuo Therapeutics Inc (QB)
      05/21/20248:30AMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:AURXNuo Therapeutics Inc (QB)
      05/15/20245:00PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:AURXNuo Therapeutics Inc (QB)
      02/14/20241:58PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsUSOTC:AURXNuo Therapeutics Inc (QB)
      02/12/20245:33PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:AURXNuo Therapeutics Inc (QB)
      12/22/202310:01AMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:AURXNuo Therapeutics Inc (QB)
      12/20/20232:18PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]USOTC:AURXNuo Therapeutics Inc (QB)
      12/20/20232:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:AURXNuo Therapeutics Inc (QB)
      12/20/20232:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:AURXNuo Therapeutics Inc (QB)
      12/20/20239:02AMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:AURXNuo Therapeutics Inc (QB)
      11/20/20234:30PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:AURXNuo Therapeutics Inc (QB)
      11/15/20239:37AMEdgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:AURXNuo Therapeutics Inc (QB)
      08/08/20232:15PMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:AURXNuo Therapeutics Inc (QB)
      08/03/20234:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:AURXNuo Therapeutics Inc (QB)
      08/03/20234:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:AURXNuo Therapeutics Inc (QB)
      08/03/20234:15PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:AURXNuo Therapeutics Inc (QB)
      05/15/20235:10PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:AURXNuo Therapeutics Inc (QB)
      04/17/20236:08AMEdgar (US Regulatory)Annual Report (10-k)USOTC:AURXNuo Therapeutics Inc (QB)
      11/14/20226:44PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:AURXNuo Therapeutics Inc (QB)
      11/04/20225:28PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:AURXNuo Therapeutics Inc (QB)
      10/20/20228:36AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:AURXNuo Therapeutics Inc (QB)
      10/20/20228:34AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:AURXNuo Therapeutics Inc (QB)
      08/30/20228:16AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:AURXNuo Therapeutics Inc (QB)
      08/10/20221:29PMEdgar (US Regulatory)Amended Quarterly Report (10-q/a)USOTC:AURXNuo Therapeutics Inc (QB)
      08/08/20224:49PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:AURXNuo Therapeutics Inc (QB)
      07/05/20228:03AMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:AURXNuo Therapeutics Inc (QB)
      07/05/20228:02AMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:AURXNuo Therapeutics Inc (QB)
      07/05/20228:02AMEdgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:AURXNuo Therapeutics Inc (QB)
       Showing the most relevant articles for your search:USOTC:AURX